Home Generics Biosimilars Docs & Positions Facts & Figures Press Room Conferences

Biosimilar Medicines | Positions

TopEGA Positions & Policy Papers on Biosimilar Medicines

EGA Position on the WHO INN Policy for Biosimilars

EGA Position
• April 2007

EGA Position on the IAPO Paper on Biosimilar Medicines

EGA Position
• December 2006

EGA’s Rationale For Continued Application of the WHO’s Longstanding INN Naming System To Biosimilars

EGA Policy Presentation [1.2 mb]
• Geneva - 13 November 2006

The Naming of Biopharmaceuticals: A Contribution to the WHO “Review of International Nonproprietary Names (INN) for Biological and Biotechnological Substances”

EGA Position
• 31 October 2006

EGA Response to the EBE-EFPIA Position Paper on Naming of Biosimilar Medicinal Products: Options for Addressing Unique Safety Concern

EGA Position
• 30 August 2006